miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow
Background. Coronary slow flow (CSF) refers to the phenomenon of delayed distal flow in the absence of lesions detected on coronary angiography. Although the detection rate of CSF has been increasing in clinical practice, early diagnosis is difficult and the factors contributing to this condition re...
Saved in:
| Main Authors: | Tong Chen, Zhen-Yu Wang, Chuan-Chang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2020/7490942 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow
by: Yuan-Ting Zhu, et al.
Published: (2020-01-01) -
Plasma thrombin-antithrombin complex as a candidate biomarker for coronary slow flow
by: Jian-hong Mo, et al.
Published: (2025-07-01) -
Utility of Urinary miRNA Biomarkers for Canine Urothelial Carcinoma Diagnostics
by: Alexandra Kehl, et al.
Published: (2025-06-01) -
Diagnostic value of miRNA-101 and miRNA-27 in acute heart transplant rejection
by: D. A. Velikiy, et al.
Published: (2021-01-01) -
Sensitivity of miRNA-181a, miRNA-23b and miRNA-16 in the Late-Onset Neonatal Sepsis: A Diagnostic Study
by: Yang Pan, et al.
Published: (2024-10-01)